Susquehanna International Group, LLP Beam Therapeutics Inc. Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 85,647 shares of BEAM stock, worth $2.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
85,647
Previous 165,763 48.33%
Holding current value
$2.48 Million
Previous $3.88 Million 45.97%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$22.57 - $33.14 $1.81 Million - $2.66 Million
-80,116 Reduced 48.33%
85,647 $2.1 Million
Q2 2024

Aug 15, 2024
BUY
$21.22 - $32.66 $1.79 Million - $2.75 Million
84,134 Added 103.07%
165,763 $3.88 Million
Q1 2024

May 07, 2024
SELL
$23.46 - $45.07 $2.33 Million - $4.47 Million
-99,110 Reduced 54.84%
81,629 $2.7 Million
Q4 2023

Feb 14, 2024
SELL
$17.69 - $30.76 $3,378 - $5,875
-191 Reduced 0.11%
180,739 $4.92 Million
Q3 2023

Nov 14, 2023
BUY
$23.01 - $32.46 $3.61 Million - $5.09 Million
156,825 Added 650.59%
180,930 $4.35 Million
Q2 2023

Aug 11, 2023
SELL
$29.32 - $35.99 $4.61 Million - $5.66 Million
-157,252 Reduced 86.71%
24,105 $769,000
Q1 2023

May 16, 2023
BUY
$30.15 - $48.79 $3.84 Million - $6.21 Million
127,212 Added 234.95%
181,357 $5.55 Million
Q4 2022

Feb 14, 2023
SELL
$36.73 - $51.6 $548,929 - $771,162
-14,945 Reduced 21.63%
54,145 $2.12 Million
Q3 2022

Nov 14, 2022
BUY
$39.79 - $70.31 $210,409 - $371,799
5,288 Added 8.29%
69,090 $3.29 Million
Q2 2022

Aug 15, 2022
SELL
$29.86 - $62.36 $264,738 - $552,883
-8,866 Reduced 12.2%
63,802 $2.47 Million
Q1 2022

May 16, 2022
SELL
$53.73 - $82.16 $1.21 Million - $1.86 Million
-22,588 Reduced 23.71%
72,668 $4.16 Million
Q4 2021

Feb 14, 2022
BUY
$68.02 - $99.06 $2.16 Million - $3.15 Million
31,770 Added 50.04%
95,256 $7.59 Million
Q3 2021

Nov 15, 2021
BUY
$84.37 - $133.6 $3.79 Million - $5.99 Million
44,868 Added 240.99%
63,486 $5.52 Million
Q2 2021

Aug 11, 2021
SELL
$64.12 - $128.71 $515,460 - $1.03 Million
-8,039 Reduced 30.16%
18,618 $2.4 Million
Q1 2021

May 17, 2021
SELL
$71.28 - $120.75 $2.96 Million - $5.02 Million
-41,547 Reduced 60.92%
26,657 $2.13 Million
Q4 2020

Feb 16, 2021
BUY
$22.24 - $95.63 $1.52 Million - $6.52 Million
68,204 New
68,204 $5.57 Million

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $2.04B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email